Genetic Analysis AS ramps up its market presence for the GA-map[®] microbiome testing in the US
OSLO, NORWAY – August 25, 2023: Microbiome diagnostics specialist, Genetic Analysis AS (“GA”) has through its distributor Eagle Biosciences Inc, entered an agreement with an undisclosed partner, a high-volume lab company providing laboratory diagnostics to clinics, public health departments and research universities in the US. The partner is expected to launch the standardized and validated GA-map® as a testing service during Q4 2023. The partnership perfectly aligns with GA´s strategy to accelerate growth through new high-volume labs and marks an important step forward in GA´s business